NWF Advisory Cuts Amgen Holdings by 41.7% Amid Market Shift
NWF Advisory Services Inc., a financial institution, has made significant adjustments to its holdings in Amgen Inc. (NASDAQ: AMGN). According to recent Form 13F filings with the Securities & Exchange Commission, NWF cut its shares in Amgen by 41.7% in the second quarter.
The company's total holdings in Amgen now stand at 5,766 shares after selling 4,116 shares during the quarter. The value of these holdings amounts to $2,088,000 as per the latest SEC filing.
Other hedge funds have also made notable changes to their stakes in Amgen. For instance, Dogwood Wealth Management LLC increased its position by a substantial 275% in the fourth quarter and now owns 75 shares worth $25,000. Anfield Capital Management LLC raised its stake by an impressive 1,000% during the same period.
The medical research company reported earnings of $6.29 per share for the quarter, beating analysts' estimates of $5.62 by $0.67. Amgen's revenue for the quarter was $10.05 billion, a 9.5% increase from last year.